DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.

The Global pharmaceutical CRO market will reach $104.4 billion by 2030, growing by 8.1% annually over 2020-2030 driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and provides a forecast from 2020 till 2030 with 2019 as the base year.

The trend and outlook of the global market is forecast in an optimistic, balanced, and conservative view by taking into account the COVID-19 pandemic. The balanced (most likely) projection is used to quantify global pharmaceutical CRO market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Region.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global pharmaceutical CRO market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

• Charles River Laboratories
• CMIC Co. Ltd
• Covance Inc.
• Hangzhou Tigermed Consulting Co Ltd
• ICON Plc
• IQVIA Holdings Inc.
• LSK Global Pharma Service Co Ltd
• Novotech Pty Ltd
• PAREXEL International Corporation
• Pharmaceutical Product Development LLC (PPD)
• PRA Health Sciences Inc.
• Quanticate Ltd
• Samsung Bioepis Co. Ltd
• SGS SA (SGS Life Sciences)
• Syneos Health Inc.
• WuXi AppTec Inc.

Key Topics Covered:

1 Introduction

1.1 Industry Definition and Research Scope

1.2 Research Methodology

1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on World Economy

2.1.2 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter’s Fiver Forces Analysis

3 Segmentation of Global Market by Service

3.1 Market Overview by Service

3.2 CRO for Pre-clinical Development

3.3 CRO for Phase I Trials

3.4 CRO for Phase II Trials

3.5 CRO for Phase III Trials

3.6 CRO for Phase IV Trials

3.7 Laboratory Services

3.8 Consulting Services

3.9 Data Management Services

4 Segmentation of Global Market by Therapeutic Application

4.1 Market Overview by Therapeutic Application

4.2 Infectious Diseases

4.3 Oncology

4.4 Metabolic Disorders

4.5 Cardiovascular Disorders

4.6 Central Nervous System

4.7 Respiratory Disorders

4.8 Gastrointestinal Disorders

4.9 Other Therapeutic Applications

5 Segmentation of Global Market by End User

5.1 Market Overview by End User

5.2 Pharmaceutical & Biopharmaceutical Companies

5.3 Medical Device Companies

5.4 Academic Institutes

6 Segmentation of Global Market by Region

6.1 Geographic Market Overview 2019-2030

6.2 North America Market 2019-2030 by Country

6.2.1 Overview of North America Market

6.2.2 U.S.

6.2.3 Canada

6.2.4 Mexico

6.3 European Market 2019-2030 by Country

6.3.1 Overview of European Market

6.3.2 Germany

6.3.3 UK

6.3.4 France

6.3.5 Spain

6.3.6 Italy

6.3.7 Russia

6.3.8 Rest of European Market

6.4 Asia-Pacific Market 2019-2030 by Country

6.4.1 Overview of Asia-Pacific Market

6.4.2 Japan

6.4.3 China

6.4.4 Australia

6.4.5 India

6.4.6 South Korea

6.4.7 Rest of APAC Region

6.5 South America Market 2019-2030 by Country

6.5.1 Argentina

6.5.2 Brazil

6.5.3 Chile

6.5.4 Rest of South America Market

6.6 MEA Market 2019-2030 by Country

6.6.1 UAE

6.6.2 Saudi Arabia

6.6.3 South Africa

6.6.4 Other National Markets

7 Competitive Landscape

7.1 Overview of Key Vendors

7.2 New Product Launch, Partnership, Investment, and M&A

7.3 Company Profiles

8 Investing in Global Market: Risk Assessment and Management

8.1 Risk Evaluation of Global Market

8.2 Critical Success Factors (CSFs)

For more information about this report visit https://www.researchandmarkets.com/r/kh3wre

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

DUBLIN–(BUSINESS WIRE)–The “Global Pharmaceutical Contract Research Organization (CRO) Market 2020-2030 by Service, Therapeutic Application, End User, and Region: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.

The Global pharmaceutical CRO market will reach $104.4 billion by 2030, growing by 8.1% annually over 2020-2030 driven by the increasing incidence of disease, rising healthcare expenditures, increasing dependence on contract research organizations due to improved efficiency and productivity.

Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies of the period 2015-2019 and provides a forecast from 2020 till 2030 with 2019 as the base year.

The trend and outlook of the global market is forecast in an optimistic, balanced, and conservative view by taking into account the COVID-19 pandemic. The balanced (most likely) projection is used to quantify global pharmaceutical CRO market in every aspect of the classification from perspectives of Service, Therapeutic Application, End User, and Region.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Specifically, potential risks associated with investing in global pharmaceutical CRO market are assayed quantitatively and qualitatively through a Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.

Key Players (this may not be a complete list and extra companies can be added upon request):

• Charles River Laboratories
• CMIC Co. Ltd
• Covance Inc.
• Hangzhou Tigermed Consulting Co Ltd
• ICON Plc
• IQVIA Holdings Inc.
• LSK Global Pharma Service Co Ltd
• Novotech Pty Ltd
• PAREXEL International Corporation
• Pharmaceutical Product Development LLC (PPD)
• PRA Health Sciences Inc.
• Quanticate Ltd
• Samsung Bioepis Co. Ltd
• SGS SA (SGS Life Sciences)
• Syneos Health Inc.
• WuXi AppTec Inc.

Key Topics Covered:

1 Introduction

1.1 Industry Definition and Research Scope

1.2 Research Methodology

1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on World Economy

2.1.2 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter’s Fiver Forces Analysis

3 Segmentation of Global Market by Service

3.1 Market Overview by Service

3.2 CRO for Pre-clinical Development

3.3 CRO for Phase I Trials

3.4 CRO for Phase II Trials

3.5 CRO for Phase III Trials

3.6 CRO for Phase IV Trials

3.7 Laboratory Services

3.8 Consulting Services

3.9 Data Management Services

4 Segmentation of Global Market by Therapeutic Application

4.1 Market Overview by Therapeutic Application

4.2 Infectious Diseases

4.3 Oncology

4.4 Metabolic Disorders

4.5 Cardiovascular Disorders

4.6 Central Nervous System

4.7 Respiratory Disorders

4.8 Gastrointestinal Disorders

4.9 Other Therapeutic Applications

5 Segmentation of Global Market by End User

5.1 Market Overview by End User

5.2 Pharmaceutical & Biopharmaceutical Companies

5.3 Medical Device Companies

5.4 Academic Institutes

6 Segmentation of Global Market by Region

6.1 Geographic Market Overview 2019-2030

6.2 North America Market 2019-2030 by Country

6.2.1 Overview of North America Market

6.2.2 U.S.

6.2.3 Canada

6.2.4 Mexico

6.3 European Market 2019-2030 by Country

6.3.1 Overview of European Market

6.3.2 Germany

6.3.3 UK

6.3.4 France

6.3.5 Spain

6.3.6 Italy

6.3.7 Russia

6.3.8 Rest of European Market

6.4 Asia-Pacific Market 2019-2030 by Country

6.4.1 Overview of Asia-Pacific Market

6.4.2 Japan

6.4.3 China

6.4.4 Australia

6.4.5 India

6.4.6 South Korea

6.4.7 Rest of APAC Region

6.5 South America Market 2019-2030 by Country

6.5.1 Argentina

6.5.2 Brazil

6.5.3 Chile

6.5.4 Rest of South America Market

6.6 MEA Market 2019-2030 by Country

6.6.1 UAE

6.6.2 Saudi Arabia

6.6.3 South Africa

6.6.4 Other National Markets

7 Competitive Landscape

7.1 Overview of Key Vendors

7.2 New Product Launch, Partnership, Investment, and M&A

7.3 Company Profiles

8 Investing in Global Market: Risk Assessment and Management

8.1 Risk Evaluation of Global Market

8.2 Critical Success Factors (CSFs)

For more information about this report visit https://www.researchandmarkets.com/r/kh3wre

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900